About Admiron Life Sciences Private Limited
Data last updated:
Admiron Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC071534. Its GSTIN is 36AAJCA0140R2ZH (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹42.39 Cr. It is led by directors including Sainadh Reddy Thatiparthi and Govinda Reddy Balineni.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.41 Cr, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹3.2 Cr (net margin -10.9%) and EBITDA of ₹2.19 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 24% over five years.
The company has about 124 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹16.44 Cr and satisfied charges of ₹98.25 Cr on record. Court records list 12 cases involving the company, including 1 filed by the company and 5 filed against it; 2 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.38 Cr; the latest was in March 2019. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Rasayan Drugs Private Limited with revenue of ₹29.92 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website admironls.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. 754 1st Floor Road No.38, Sri Swamy Ayyappa Society, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Admiron Life Sciences Private Limited
The main business activity of Admiron Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Admiron Life Sciences Private Limited FY 2024 filings available
Admiron Life Sciences Private Limited reported revenue of ₹29.41 Cr (down 43% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Admiron Life Sciences Private Limited
Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Admiron Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.19 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.2 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Admiron Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -10.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Admiron Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Admiron Life Sciences Private Limited
Admiron Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rasayan Drugs Private Limited | ₹29.92 Cr (FY 2024) | •••• | •••• | 132.0% | •••• | Solapur, Maharashtra, India |
| Avencia Molecules Private Limited | ₹29.89 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Bharuch, Gujarat, India |
| Lofty Laboratories Private Limited | ₹29.82 Cr (FY 2025) | •••• | •••• | 119.0% | •••• | Hyderabad, Telangana, India |
| Magnum Chemi-Gran Private Limited | ₹29.74 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Hyderabad, Telangana, India |
| Mahrshee Organics Private Limited | ₹29.58 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Panoli, Gujarat, India |
| Admiron Life Sciences Private Limited this company | ₹29.41 Cr (FY 2024) | •••• | •••• | -43.0% | •••• | Hyderabad, Telangana, India |
| G.M. Chemie Private Limited | ₹29.36 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Navi Mumbai, Maharashtra, India |
| Trimax Bio Sciences Private Limited | ₹29.26 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | Hyderabad, Telangana, India |
| Stellence Pharmscience Private Limited | ₹29.16 Cr (FY 2022) | •••• | •••• | -16.0% | •••• | Bangalore, Karnataka, India |
| Sri Haas Life Sciences Private Limited | ₹28.99 Cr (FY 2025) | •••• | •••• | 60.0% | •••• | Hyderabad, Telangana, India |
| Asg Biochem Private Limited | ₹28.92 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Admiron Life Sciences by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Admiron Life Sciences Private Limited
Admiron Life Sciences Private Limited is audited by SARATH & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SARATH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Admiron Life Sciences Private Limited
Admiron Life Sciences has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sainadh Reddy Thatiparthi Also directs: Aarishi Medkare Private Limited, Pranaya Life Sciences Private Limited, Pranaya Parenterals Private Limited and 2 more | Director | 08 Jul 2023 | 3 Years 3 Months | Current |
| Govinda Reddy Balineni | Director | 23 Dec 2019 | 6 Years 9 Months | Current |
| Kanigiri Gade Also directs: Aarishi Medkare Private Limited, Pranaya Life Sciences Private Limited, Pranaya Parenterals Private Limited and 1 more | Director | 08 Jul 2023 | 3 Years 3 Months | Current |
Ownership and Shareholding of Admiron Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Admiron Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2021 | Hdfc Bank Limited | ₹16.25 Cr | Open |
| 31 Dec 2020 | Others | ₹18.7 Lakh | Open |
| 24 Dec 2013 | State Bank of Hyderabad | ₹59.25 Cr | Satisfied |
| 07 Jul 2012 | State Bank of Hyderabad | ₹39 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Admiron Life Sciences Private Limited
Admiron Life Sciences Private Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.38 Cr; the latest was in March 2019.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Aarishi Medkare Private Limited , an individual Seller: 4 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Pranaya Pharmacy INC Seller: Pranaya Realtors INC |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2014 | Funding round | ₹13.24 Cr | Investors: Shrineeta Pharmacy INC, 3 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Admiron Life Sciences Private Limited
Admiron Life Sciences Private Limited has 12 court cases on record: 1 filed by Admiron Life Sciences, 5 filed against it, 6 where it is another party. 2 cases are pending and 10 are disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 5 | 0 |
| High courts | 5 | 0 | 2 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by Black Rose Trading Private Limited | Disposed |
| High Court for State of Telangana | Writ petition | Company is another party | Pending |
| High Court of Andhra Pradesh | Revision petition | Company is another party | Pending |
| High Court for State of Telangana | Writ petition | Company is another party | Disposed |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against State of Andhra Pradesh | Disposed |
Full case history
All 12 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Admiron Life Sciences Private Limited
Admiron Life Sciences Private Limited has a workforce of 124 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Admiron Life Sciences Private Limited
Admiron Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2010PTC071534. The current CIN is U24232TG2010PTC071534, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC071534 | Current |
| U24232AP2010PTC071534 | Previous |
Recent Activity on Admiron Life Sciences Private Limited
Admiron Life Sciences Private Limited has 13 board changes on record since 2019: 3 appointments and 10 cessations. The latest: Kanigiri Gade was appointed as Director on 08 Jul 2023.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Admiron Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Admiron Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Admiron Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Admiron Life Sciences Private Limited
Admiron Life Sciences has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCA0140R2ZH | Telangana | Active | 11 Jan 2019 |
| 37AAJCA0140R1ZG | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Admiron Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Admiron Life Sciences Private Limited
Admiron Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 December 2010 (16+ years old) and is registered under CIN U24232TG2010PTC071534.
Admiron Life Sciences reported revenue of ₹29.41 Cr for FY 2024 (down 43% YoY).
Admiron Life Sciences has 3 current directors:
- Sainadh Reddy Thatiparthi - Director
- Govinda Reddy Balineni - Director
- Kanigiri Gade - Director
Admiron Life Sciences reported a net loss of ₹3.2 Cr (net margin -10.9%) and EBITDA of ₹2.19 Cr (EBITDA margin 7.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Admiron Life Sciences is 9% over three years and 24% over five years. In the latest year (FY 2024) revenue fell 43%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Admiron Life Sciences is 36AAJCA0140R2ZH, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AAJCA0140R1ZG (Andhra Pradesh).
The CIN (Corporate Identification Number) of Admiron Life Sciences is U24232TG2010PTC071534. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Admiron Life Sciences has 12 court cases on record: 1 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.
Admiron Life Sciences was incorporated on 06 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
Admiron Life Sciences has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.38 Cr; the latest was in March 2019.
The peers of Admiron Life Sciences by revenue are Rasayan Drugs Private Limited, Avencia Molecules Private Limited, Lofty Laboratories Private Limited, Magnum Chemi-Gran Private Limited, Mahrshee Organics Private Limited and 5 more, all in the Pharma industry (API Manufacturers).